Accenture Accenture PLC (ACN) just made a major move to bulk up its artificial intelligence muscle. The consulting and technology services giant announced Monday that it has completed its acquisition of Faculty, a top UK-based AI company. The deal, which was first announced back on January 6, brings more than 400 AI professionals—including data scientists and engineers—into the Accenture fold.

Think of it as Accenture buying a whole new brain trust. And in a telling sign of how serious they are about this, they're putting the head of that brain trust in charge of their entire technology strategy. Dr. Marc Warner, the CEO and co-founder of Faculty, is now Accenture's new Chief Technology Officer. He's also joining the company's Global Management Committee, which is basically the inner circle that runs the show.

Accenture didn't say how much it paid for Faculty. The company had a hefty war chest of about $9.65 billion in cash and equivalents as of late November last year, so it had the funds to make a strategic bet. The goal is clear: become the go-to partner for companies trying to reinvent themselves with AI.

"Now that Faculty is part of Accenture, we will further advance our strategy to be our clients' reinvention partner of choice and lead in the safe, widespread adoption of AI," said Accenture Chair and CEO Julie Sweet. She added that she's looking forward to working with Warner "to shape our technology strategy and execution and attract the best talent in the world to meet our clients' needs."

So, what exactly is Accenture getting? Faculty, founded in 2014, isn't just a team of smart people. It brings a specific product called FrontierTM to the table. It's an enterprise decision intelligence platform designed to help big organizations connect their data, AI models, and business processes. In simpler terms, it helps companies actually use AI to make better decisions, not just run experiments in a lab.

Warner framed the moment as a critical one. "As AI advances rapidly, the next few years will be hugely consequential for the world," he noted. Accenture and Faculty aren't starting from scratch; they've already been working together to support clients in life sciences, helping firms like Novartis transform how they plan clinical trials.

Manish Sharma, Accenture's Chief Strategy and Services Officer, sees massive potential in combining forces. "By combining our AI capabilities with Faculty's highly skilled AI talent and products like FrontierTM, we will help clients safely apply and scale AI to reinvent their operations—connecting data, processes, and people to drive faster value and increase competitiveness," he stated.

In early market action Monday, shares of Accenture were down slightly.